On September 19, the 2025 Review Committee Meeting on CSBT Group Standards and Expert Consensus was held in Lanzhou. The meeting was focused on improving the standardization in the field of blood collection, supply and transfusion, and promoting the coordinated progress of regulations and technologies. During the meeting, a centralized review of projects including the project proposal approval, re-evaluation and final review of group standards, and expert consensus proposal approval was conducted. LIN Junjie, Chair of CSBT/BM presided over the meeting.

In the meeting, ZHU Yongming, President of CSBT, put forward two requirements. Initially, it is essential to leverage the pivotal role of group standards and expert consensus in guiding industry development. Guided by the industrial needs of technological innovation, efforts should focus on the upgrading of blood and other medical technologies, and the advancement of information technology and artificial intelligence, so as to provide technical supplements for the refinement of the blood standardization system. Moreover, it is imperative to encourage all branches, group standards and expert consensus initiators to conduct in-depth interpretation among member institutions. The effective application of these outcomes should be promoted by leveraging informatization, digitalization, and intelligentization tools.

This meeting conduct both offline and online reviews of four group standards (final-stage assessment), eight released group standards (re-evaluation), three group standard project proposals (initiation review), and five expert consensus project proposals (initiation review). The expert panel conducted strict review based on compliance, rationality, feasibility, scientificity, and advancement. Furthermore, expert discussed on technical key points and implementation specifics, and proposed refinement suggestions. Following a voting process, all projects progressed smoothly. The review outcomes were pending submission for CSBT approval prior to their official release. 

This review will further enhance the group standard system, facilitate technological innovation, advance the industry’s standardization progress, and continuously enable high-quality development of the blood transfusion. It is anticipated that under the guidance of these group standards, the blood industry will becom more standardized, scientific, and digitalized.

Source: CSBT Secretariat;

Translated by CHEN Xiaoli;

Reviewed by FENG Chenchen, ZHU Shanshan.